Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: Cancer. 2016 Jan 13;122(6):946–953. doi: 10.1002/cncr.29872

Table 2.

Mitochondrial Parameters and Treatment

n DOX Median (range) n DEX+DOX Median (range) P-value
MtDNA copies/cell 27 1106.3 (144.2-6746.8) 35 310.5 (15.3-1859.2) 0.001
CI activity (OD/μg × 103) 25 10.5 (5.0-31.3) 33 11.7 (5.0-41.4) 0.97
CIV activity (OD/μg × 103) 25 9.8 (5.0-20.1) 34 8.1 (4.7-23.4) 0.40

CI, Complex I; CIV, Complex IV; DOX, doxorubicin; DEX, dexrazoxane; DEX+DOX, administration of dexrazoxane prior to every doxorubicin treatment; OD, optical density.